At the Medika general assembly, convened for October 28, shareholders will decide on the proposal to retain the majority of last year’s net profit, 61.3 million kuna, for reinvestment, i.e., for increasing share capital.
The Management and Supervisory Board of Medika propose that from last year’s net profit, which amounts to 61.46 million kuna, 61.29 million kuna be allocated to retained earnings for the purpose of reinvestment, i.e., for increasing share capital, while the remaining 174.6 thousand kuna will be allocated to retained earnings. The assembly is also proposed to make a decision on increasing share capital from 134.96 to 196.26 million kuna. The share capital is increased from the profit of 2014 transferred to retained earnings.
The increase in share capital will be implemented in such a way that the value of each of the 30,194 shares with a nominal amount of 4,470 kuna will be increased by an amount of 2,030 kuna, i.e., to 6,500 kuna.
The assembly is also proposed to make a decision on the payment of a dividend of 2,650 kuna per share from retained earnings generated until the end of 2000 to all shareholders who were recorded as their owners on June 30 of this year, with the note that it will be paid only to those shareholders who have not yet received it. Namely, the dividend was paid to part of the shareholders in the period from July 9 to July 22 of this year, after which the payment was suspended due to the receipt of a non-final Decision from the Commercial Court in Zagreb regarding the issuance of temporary measures that halted the implementation of all decisions made at the General Assembly on June 30 of this year.
